🐋 NBIS $14M Deep-ITM LEAP — Whale Loads Up on a 2.5-Year Stock-Replacement Bull Bet

📅 May 21, 2026 | 🔥 Unusual Options Activity Detected

May 22 OI update: The May 22 OPRA snapshot confirmed the Dec 2028 $180 call OI rose by exactly +1,000 (from 3,839 to 4,839), matching the trade size precisely — this was a fresh open.

---

📊 Company Overview

Nebius Group N.V. (NASDAQ: NBIS) is an AI-cloud and GPU-infrastructure company spun out of the former Yandex N.V., now operating as one of the most ambitious AI-infrastructure builders outside of the hyperscalers.

• Market Cap: ≈$50–51 billion (mid-May 2026)
• Industry: AI Cloud / GPU Infrastructure
• Sector: Technology — Electronic Computers
• Current Price: $221.78 (intraday, May 21, 2026), near the all-time high of $233.73 set May 14
• What they do: Nebius builds and operates GPU data centers — the physical backbone that AI companies use to train models and run inference. They are not an AI model company; they are the picks-and-shovels infrastructure layer. Their anchor relationships include a $27 billion five-year compute agreement with Meta, a $17.4–19.4 billion Microsoft GPU deal, and a $2 billion strategic equity investment from NVIDIA that also grants Nebius early access to next-generation Rubin and Vera hardware.

---

🎯 The Quick Take

Someone just dropped $14 million on deep in-the-money NBIS calls expiring in December 2028 — more than two and a half years out. At a $180 strike with the stock at $221.78, this is not a lottery ticket or a short-term directional bet. It is a stock-replacement LEAP: a structure that participates in nearly every dollar of upside with a delta north of 0.85, while capping the maximum loss at the premium paid. This is the third large bullish NBIS bet we have tracked in recent days, following a $28 million Jan'27 $210 call position that printed May 18–19. The whale is not dabbling. They are accumulating multi-year exposure to Nebius's thesis of converting a $46 billion+ contracted backlog into profitable, recurring AI-cloud revenue.

---

💰 The Option Flow Breakdown

📊 What Just Happened — The Tape (May 21, 2026 @ 11:03:43 ET)

---

✅ RESOLVED — Fresh Open Confirmed (May 22, 2026)

The May 22 OPRA open-interest snapshot has resolved the open/close question definitively:

Verdict: The May 22 OI rose by exactly 1,000 (the trade size), confirming this was a fresh deep-ITM stock-replacement LEAP open — a genuine new multi-year bullish position, not a roll or close.

---

🤓 What This Actually Means

Deep-ITM LEAP = stock replacement, not speculation.

Here is the mechanics in plain language. The Dec 2028 $180 call has a delta of roughly 0.85+, which means it moves ≈$0.85 for every $1.00 that NBIS shares move. For practical purposes, the trader has near-stock exposure but paid $140.84 per share (the option premium) instead of $221.78 per share (the stock price). They control the same economic exposure but deployed 37% less capital, and their maximum downside is capped at the premium paid — $14 million total — versus potentially more if holding actual stock on margin.

This is not someone guessing NBIS spikes next week. This is someone saying: "I believe NBIS stock will be substantially higher over the next 2.5 years and I want near-full participation in that upside while defining my worst-case loss."

For the position to break even at expiration, NBIS needs to trade at or above the strike plus the option premium paid: $180 + $140.84 = $320.84 by December 2028. That is ≈45% above today's spot. For reference, the stock is already up ≈50% from its late-April 2026 base near $145.

Context on size: 1,000 contracts = rights to 100,000 shares. At $221.78 spot, that is $22.2 million of equivalent stock exposure purchased for $14 million. The premium efficiency is the entire point of the structure.

This is the third large NBIS bull bet tracked in May 2026. A $28M Jan'27 $210 call block printed May 18–19. The pattern of repeated large-premium bullish opening positions in Nebius is meaningful — it suggests conviction across multiple entities or a single entity building a layered position across different expirations.

---

📈 Technical Setup / Chart Check-Up

YTD Performance

NBIS entered 2026 with significant momentum and has delivered a remarkable run. The stock gained 33.2% in April 2026 alone, reached an all-time high of $233.73 on May 14, 2026 following the Q1 2026 earnings report, and is trading around $221.78 today. The YTD move off late-April lows near $140–$150 is ≈+50%.

Key chart observations:

• 📈 Multiple catalyst-driven gap moves: +14% on the Meta deal (March 16), +40–60% on the Microsoft deal (September 2025), +16% on the NVIDIA equity investment (March 12), and +16% today on the Bloom Energy fuel-cell power deal
• 🏔️ Stock is within 5% of all-time highs, which is where you would expect a high-conviction LEAP buyer to act — not at the top of a spike, but near ATH confirming trend strength
• ⚠️ The rapid advance from $145 to $233 in under 30 days followed by today's pullback to $221 suggests near-term digestion is possible before the next leg

Gamma-Based Support & Resistance Analysis

The gamma exposure map is the market-maker playbook for where price is likely to attract or repel activity in the near term.

🟠 Resistance Levels (Call Gamma Above Current Price):

• $220 — The strongest and most immediate resistance, with 6.02 total gamma (designated "Strong" by the model). This is ≈0.27% above the GEX snapshot price of $219.4. With NBIS currently trading at $221.78, the stock has already nudged through this level intraday. Market makers with short gamma exposure here will sell into rallies to hedge, creating friction. Watch this zone closely.
• $230 — Moderate resistance at 3.01 total gamma, roughly 4.8% above the GEX snapshot price. A clean break and hold above $220 targets $230 as the next friction zone.

🔵 Support Levels (Put Gamma / Support Walls Below Current Price):

• $200 — The primary support wall with 5.15 total gamma. This is the level where market-maker hedging flows systematically buy dips. It sits ≈8.8% below the GEX snapshot price. For the bull thesis to remain intact, $200 needs to hold on any meaningful drawdown.
• $215 — Secondary cluster with 1.73 total gamma (call-heavy, net positive GEX ≈0.75), acting as an intermediate floor roughly 2% below the snapshot reference.
• $210 — Additional support cluster at 2.51 total gamma, ≈4.3% below snapshot price. This zone corresponds to the Jan'27 $210 call strike from the May 18–19 whale bet — not coincidental.

Net GEX Bias: Call gamma dominates the nearby strikes, suggesting overall bullish positioning from market makers. The stock's position between the $220 resistance wall and the $200 support wall defines the current trading corridor.

What this means for the LEAP buyer: They bought a $180 strike that is already $40+ in-the-money, well below the support wall at $200. The gamma structure suggests that as long as NBIS holds above $200, the structural floor is intact. A break below $200 would be a meaningful technical deterioration.

Implied Move Analysis

The options market is pricing in significant volatility across all timeframes — which makes sense for a high-growth, early-stage company with concentrated catalyst risk.

Translation for regular folks:

Options traders are pricing in a ±4.4% move ($9.63) by tomorrow's weekly expiry — so any close above $229 or below $210 would be an "outside the expected range" outcome for this week.

The monthly OPEX number is the headline: a ±35% implied move ($77.43) through June 19, 2026. That is a massive range — the options market is saying NBIS could plausibly trade anywhere from $142 to $297 over the next 29 days. For context, this reflects:

1. The stock's underlying volatility profile (a GPU-cloud neocloud near ATH with a $50B cap is inherently volatile)
2. The approach of the Q2 2026 earnings on August 6 — while not within the June 19 window, any management guidance updates or contract announcements between now and then will move the stock sharply

What this means for the LEAP buyer: The wide implied move tells you the market is NOT efficiently pricing in a quiet, steady grind upward. Large moves in both directions are expected. The LEAP structure makes sense precisely because it provides multi-year exposure without the daily volatility risk of owning the stock outright — the worst case is losing the $14M premium, not getting stopped out on a 10% drawdown.

---

🎪 Catalysts

🔥 Recent Catalysts That Drove the Rally

• Q1 2026 Earnings (reported May 13, 2026): Revenue +684% year-over-year to $399 million, Nebius AI segment revenue +841% YoY, and core AI-cloud ARR reaching ≈$1.9 billion. Management reaffirmed FY2026 revenue guidance of $3.0–3.4 billion and ≈40% adjusted EBITDA margin. Stock hit ATH $233.73 in the wake of the print.

• Meta $27B AI-infrastructure deal (March 16, 2026): Five-year deal for $12 billion dedicated capacity plus up to $15 billion additional compute using the NVIDIA Vera Rubin platform, with delivery starting early 2027. Shares surged ≈14% on the announcement.

• Microsoft $17.4B GPU supply agreement (September 2025): Five-year deal served largely out of Nebius's Vineland, NJ data center. Deliveries are ramping in Q3–Q4 2026.

• NVIDIA $2B strategic investment (March 11–12, 2026): NVIDIA took an equity stake and committed to full-stack collaboration — early access to Rubin/Vera/BlueField hardware and "Exemplar Cloud" status. Shares rose ≈16%.

• Bloom Energy $2.6B fuel-cell power deal (May 20–21, 2026): Nebius committed up to $2.6 billion in service fees for ≈250–328 MW of guaranteed fuel-cell power across three phases on 10-year terms — directly de-risking the power-supply bottleneck on the US build-out. NBIS rose ≈16% today on the news.

• $46B+ cumulative contracted backlog: The sum of Meta + Microsoft and other agreements, giving Nebius multi-year revenue visibility rare for a sub-$60B company.

📅 Upcoming Catalysts (Next 6 Months)

• Q2 2026 Earnings — August 6, 2026 (the single most important near-term catalyst): Consensus EPS ≈ −$0.69 on an operating basis (the company remains loss-making as it builds out capacity). Key metrics to watch: sequential ARR progression toward the $7–9B FY exit-rate, Microsoft delivery ramp in H2, contracted-power figure vs. the 3.5 GW already secured (target: 4 GW), and capex pacing within the $20–25B range. Management pre-guided Q2 margins "a little bit lower" before recovering in H2.

• Microsoft H2 delivery ramp: Management flagged Q3–Q4 2026 as the ramp period for Microsoft backlog conversion. Each confirmed delivery milestone is a discrete stock catalyst.

• Back-half capacity build: Connected power of 800 MW–1 GW expected by year-end 2026; contracted power already at 3.5 GW targeting 4 GW. The Bloom Energy first 328 MW installation is slated for operational status this year.

• Potential new hyperscaler contracts: Nebius has described capacity as "sold out" with demand exceeding supply — additional contract announcements are possible but not confirmed.

• Q3 2026 Earnings — expected early-to-mid November 2026: This should be the first print to reflect meaningful H2-weighted capacity and the beginning of the Microsoft ramp.

---

🎲 Price Targets & Probabilities

Using the gamma S/R levels and implied-move data above, here are the three scenarios through the medium term (not the 2028 LEAP expiry — that is its own story):

📈 Bull Case — $250–$300 (30% probability)

How we get there:

• ✅ Q2 August 6 earnings shows ARR tracking toward the $7–9B FY exit-rate ahead of schedule
• 🚀 Microsoft H2 delivery milestones confirm on schedule — revenue recognition inflects
• ⚡ Bloom Energy first 328 MW fuel-cell installation comes online, removing power-bottleneck risk premium
• 🏆 Goldman Sachs $205 Buy target gets revised upward; consensus target migrates toward $250–$290 range (currently ≈$221 average per TipRanks)
• 📊 Stock pushes through the $230 gamma resistance and discovers thin air above — call gamma above $230 thins out rapidly, so breakouts tend to be fast and extended
• 🔥 Implied-move upper range for June 19 OPEX: $296.83 — the options market itself assigns non-trivial probability to a print near $300 within 29 days

LEAP context: At $300, the Dec 2028 $180 call with 2.5 years remaining would be worth well north of $120 of intrinsic value alone, plus substantial remaining time value. This position looks like a winner.

🎯 Base Case — $200–$235 consolidation (50% probability)

Most likely scenario:

• ✅ Stock digests its massive run from $145 to $233 in under a month
• ⚖️ Q2 earnings on August 6 meet or slightly beat a modest consensus (−$0.69 EPS operating loss is already low-bar)
• 📊 Stock remains range-bound between the $200 gamma support wall and the $230–$235 gamma resistance band
• 🔄 Microsoft deliveries begin but ramp slowly through Q3, with the real step-up deferred to Q4
• 💤 No new major hyperscaler contract signed in the interim

LEAP context: With 2.5 years of time remaining, the Dec 2028 $180 call retains substantial time value even if the stock drifts sideways. Theta decay at this expiration length is slow — this position does not bleed out in a flat market the way short-dated options do.

📉 Bear Case — $140–$200 pullback (20% probability)

What could go wrong:

• 😰 Q2 August 6 earnings disappoints on ARR progression — management's "a little lower" Q2 margin warning becomes a bigger miss than expected
• 💸 Capex guidance of $20–25 billion spooks investors as cash burn runs ahead of revenue recognition
• 📉 Microsoft delivery delays push H2 revenue acceleration into 2027 — backlog remains paper, not cash
• 🇺🇸 Macro deterioration cools AI-capex budgets; Meta or Microsoft signal any reduction in AI infrastructure spending
• ⚠️ Morgan Stanley's $144 Equal-weight target implies ≈35% downside from current levels — this is a serious counterweight to the Goldman $205 Buy
• 📊 Implied-move lower range for June 19 OPEX: $141.97 — the options market puts measurable probability on a return to ≈$142

LEAP context: In the bear case, the LEAP loses time value rapidly if the stock drops sharply. However, the $14M maximum loss is defined and fixed — the trader cannot lose more than that regardless of how far NBIS falls.

---

💡 Trading Ideas

🛡️ Conservative — Own the Stock on a Pullback

Play: Wait for a retracement to the $200 gamma support wall before initiating a stock position.

Why this works:

• 🔵 $200 is the primary gamma support wall from the GEX data — dealer hedging flows buy dips here systematically
• 💸 Buying at $200 vs. today's $221.78 provides ≈10% margin of safety on an already high-momentum stock
• 📊 Defined entry point with a clear "this is wrong" signal: close below $195 on elevated volume
• 🎯 If the bull thesis is correct, buying at $200 and targeting $250–$280 over the next 6 months is a reasonable risk/reward

Position sizing: Treat this as a growth allocation — no more than 3–5% of a portfolio given the volatility profile (35%+ implied move over 29 days tells you this is not a slow mover).

Risk level: Moderate | Skill level: Beginner-friendly

⚖️ Balanced — Sell a Cash-Secured Put at $200

Play: Sell the July or August $200 puts to collect premium while waiting for the pullback entry.

Why this works:

• 💰 Collect premium income (exact level depends on current bid-ask; check live pricing) while defining an entry at the gamma support floor
• ⏰ If NBIS stays above $200 through expiry, you keep the premium outright — getting paid to wait
• 🎯 If NBIS drops to $200 or below, you acquire shares at your target price, effectively lowering your cost basis by the premium collected
• 📅 August expiry captures the Q2 earnings catalyst — elevated IV into August 6 makes premium collection more attractive

Risk: You are obligated to buy 100 shares per contract at $200 if assigned — make sure you have the capital and conviction to own NBIS at $200.

Risk level: Moderate (defined, obligation-based) | Skill level: Intermediate

🚀 Aggressive — Replicate the Whale Trade at Smaller Size

Play: Buy the NBIS Dec 2028 $180 call (NBIS20281215C180) at 1–5 contracts.

Why this makes sense:

• 🐋 You are buying the exact same structure as the $14M whale — deep ITM, near-stock delta, 2.5-year duration
• 🛡️ Defined max loss (the premium paid) with near-full stock participation on the upside
• ⏰ 2.5 years of duration gives the thesis time to play out through Q2 (August), Q3 (November), and into the Meta Vera Rubin revenue ramp that begins early 2027
• 📊 The position benefits from any positive re-rating of Nebius's valuation multiple as ARR tracks toward $7–9B

Real risks:

• ❗ At $140.84 per contract, 1 contract costs $14,084 — this is not a small-dollar trade
• ❗ Breakeven at expiry requires NBIS at $320.84 — a 45% appreciation from today
• ❗ Liquidity: NBIS options are not SPY. Check the bid-ask spread carefully; enter with a limit order
• ❗ Vol/OI ambiguity noted above — wait for Friday's OI snapshot before committing if the open/close question matters to your thesis

Risk level: High (but defined) | Skill level: Intermediate to Advanced

---

⚠️ Risk Factors — What Could Go Wrong

Options trading involves substantial risk. Here are the honest challenges with the NBIS bull thesis:

• 💸 Capex shock risk: 2026 capex guidance is $20–25 billion against guided revenue of $3.0–3.4 billion. The company is spending 6–8x its annual revenue on build-out. Funding comes from ≈$4.3 billion in convertible senior notes (with potential future dilution) and equity. Any slippage in delivery or demand compresses returns on that spend painfully.

• ⏰ Execution concentrated in H2 2026: Management explicitly described 2026 capacity as back-half weighted. If the H2 ramp slips by even one quarter, the FY exit-rate ARR target moves out of reach. The December 2028 LEAP gives time for this, but near-term investors face real volatility.

• 📉 Earnings-quality question: Q1's headline EPS beat of $2.11 was almost entirely a ≈$780.6 million non-cash gain from revaluing a ClickHouse equity stake. On an operating basis, the company lost $100.3 million. Q2 consensus is −$0.69 EPS operating loss. Investors who do not look through the accounting noise can be caught by GAAP surprises in either direction.

• 🎯 Valuation near consensus target: At ≈$50 billion market cap on ≈$3B+ guided revenue, NBIS already trades near the TipRanks analyst average price target of ≈$221.71. Morgan Stanley's $144 Equal-weight target represents ≈35% downside if the ramp disappoints. The stock is priced for excellent execution.

• 🔗 Customer concentration: A very large share of contracted backlog sits with two customers — Meta and Microsoft. Any change in their AI-capex priorities would be material. Meta has guided up to $135 billion in AI capex this year — a massive tailwind, but also a single point of dependency.

• ⚡ Power bottleneck not fully resolved: The Bloom Energy deal reduces the risk but does not eliminate it. Building out 328 MW of fuel-cell infrastructure on a compressed timeline introduces commissioning risk. Additional sites in the pipeline (New Jersey, Pennsylvania gigawatt-scale campus) are still execution-dependent.

• 🖥️ NVIDIA GPU allocation dependency: The entire Nebius thesis rests on maintaining front-of-line access to NVIDIA Rubin and Vera chips. Any shift in NVIDIA's allocation priorities — or a delay in Rubin delivery — caps Nebius's growth directly.

• 🎢 Implied volatility is high: The ±35% implied move over 29 days means options premiums are expensive across the board. Strategies that involve buying options outright require larger moves to be profitable than in lower-vol environments.

---

🎯 The Bottom Line

Here's the deal: Three large bullish bets on NBIS have printed in four days — a $28M Jan'27 $210 call block (May 18–19) and today's $14M Dec 2028 $180 deep-ITM LEAP. The structure of the most recent trade says everything: deep in-the-money, 2.5-year duration, near-stock delta. This is not a trader betting on a short-term pop. This is a multi-year, high-conviction position on Nebius executing its backlog conversion.

What this trade tells us:

• 🎯 Someone believes the $46B+ contracted backlog (Meta, Microsoft) will translate into delivered, profitable ARR over the 2026–2028 window — not just revenue, but margin expansion as the fixed-cost GPU infrastructure is fully utilized
• 💰 The deep-ITM structure tells us the trader does NOT want to be leveraged-speculative — they want near-stock economics with a defined loss cap. That is the choice of a patient, high-conviction investor, not a YOLO gambler
• 📅 The 2028 expiry deliberately spans Q2 earnings (August 6), the Microsoft H2 ramp, the Bloom Energy commissioning, the Meta Vera Rubin delivery starting early 2027, and multiple quarters of ARR scaling beyond
• ✅ May 22 OI confirmed: The OPRA snapshot showed OI rising from 3,839 to 4,839 (+1,000 = trade size) — this is definitively a fresh long

If you are a NBIS bull:

• ✅ The gamma floor at $200 is your key level — as long as that holds, the structural support is intact
• 📅 Mark August 6, 2026 in red — Q2 earnings is the first real test of whether the $7–9B ARR exit-rate is on track
• 🎯 A pullback to $200–$210 would be the highest-quality entry point given the gamma support and the ≈10% margin of safety vs. today's price
• ⚠️ Size any position you take for the volatility — this is a ±35% implied-move stock, not a blue chip

If you are watching from the sidelines:

• ✅ The May 22 OI print confirmed this $14M bet is a fresh open — bullish confirmation is in
• ⏰ The next clear fundamental catalyst is August 6 earnings — patience pays here
• 📊 Watch the $220 gamma resistance. A clean daily close above $220 with volume, especially after Friday's OI confirmation, would be a meaningful technical signal

If you are skeptical:

• 📉 Morgan Stanley's $144 Equal-weight target is a serious counterpoint — the ramp is back-half weighted, the company is operating at a loss, and the stock has already run 50% off April lows
• 🛡️ If the thesis is wrong, the $14M maximum loss is defined — the LEAP buyer knows exactly what they can lose. Retail investors considering replication should be equally clear-eyed about their maximum downside before entering

Mark your calendar:

• ✅ May 22, 2026 — OPRA OI snapshot confirmed fresh open (+1,000 OI = trade size)
• 📅 June 19, 2026 — Monthly OPEX; implied-move range $141.97–$296.83
• 📅 August 6, 2026 — Q2 2026 earnings (single most important near-term catalyst)
• 📅 Q3–Q4 2026 — Microsoft delivery ramp, 4 GW power milestone, Bloom Energy first commissioning
• 📅 Early 2027 — Meta Vera Rubin deliveries begin (outside 6-month window but the LEAP spans it)
• 📅 2028-12-15 — LEAP expiration

The AI-infrastructure build-out is a multi-year structural theme. Nebius has assembled a credible set of contracts, equity backing, and hardware access to be a real player in it. The whale clearly agrees. But "credible" and "flawlessly executed" are different things, and at $50 billion of market cap on $3 billion of guided revenue, the market is pricing in execution without meaningful stumbles.

Be informed. Be patient. Protect your capital.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. Past options flow does not guarantee future results. The trade described involves significant premium outlay ($14 million institutional; any retail replication involves real capital at risk). Deep in-the-money LEAPS can lose their entire premium value. Always conduct your own research and consult a licensed financial advisor before trading. The May 22 OPRA OI snapshot has confirmed the open/close classification as a fresh open (BTO).

---

About Nebius Group N.V.: Nebius Group (NASDAQ: NBIS) is an AI-cloud and GPU-infrastructure operator spun out of the former Yandex N.V., with a market cap of ≈$50–51 billion. The company builds and operates large-scale GPU data centers serving AI training and inference workloads, anchored by a $27B Meta deal, a $17.4B Microsoft agreement, and a $2B NVIDIA strategic equity investment. The company reported Q1 2026 revenue of $399 million (+684% YoY) and is guiding for FY2026 revenue of $3.0–3.4 billion with an exit-rate ARR of $7–9 billion.

---

Published: May 21, 2026 | Last updated: May 22, 2026